Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?

Magdalena MeszarosJose Ursic-BedoyaStéphanie FaureGeorges-Philippe Pageaux

Published in: Hepatology (Baltimore, Md.) (2020)

We have read with great interest the article by Jucaud et al. (1) reporting that de novo donor-specific HLA antibodies (dnDSA) development during immunosuppression (IS) withdrawal in liver transplantation (LT) was associated with acute rejection and prevented further attempts of IS withdrawal. This article is protected by copyright. All rights reserved.

Keyphrases

liver failure
immune response
respiratory failure
drug induced
single molecule
adverse drug
aortic dissection
emergency department
hepatitis b virus
intensive care unit
mechanical ventilation